Testosterone replacement therapy

被引:9
|
作者
Velazquez, E [1 ]
Arata, GB [1 ]
机构
[1] Univ Los Andes, Sch Med, Dept Med, Endocrinol Unit, Merida, Venezuela
来源
ARCHIVES OF ANDROLOGY | 1998年 / 41卷 / 02期
关键词
male hypogonadism; testosterone replacement;
D O I
10.3109/01485019808987949
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
The benefits conferred by testosterone replacement therapy are substantial, both in the short term for the eradication of symptoms of androgen deficiency, and in the long term for the prevention of osteoporosis. As with any long-term treatment there are risks that must be considered, but overall the benefits achieved far outweigh potential risk. Ideally, androgen replacement therapy should provide physiological serum testosterone levels, as well as DHT and estradiol levels, and correct the clinical symptoms of androgen deficiency in hypogonadal men. This goal is difficult to achieve because the dose dependency of androgen-dependent physiological processes is not known. Androgen preparations that are currently available do not fulfill all criteria for an ideal androgen replacement therapy. Parenteral testosterone esters are effective, safe, practical, and inexpensive. The transdermal testosterone systems provide an alternative to testosterone esters in selected patients but these preparations are expensive. Ongoing studies are showing the benefits of testosterone replacement therapy in aging men, but there is concern about side effects on cardiovascular system and prostate. Thus, clinical decision regarding testosterone therapy in older men should be better defined.
引用
收藏
页码:79 / 90
页数:12
相关论文
共 50 条
  • [21] Testosterone replacement therapy and cardiovascular disease
    Jeremy M. Auerbach
    Mohit Khera
    International Journal of Impotence Research, 2022, 34 : 685 - 690
  • [22] Testosterone replacement therapy and prostate cancer
    Morgentaler, Abraham
    UROLOGIC CLINICS OF NORTH AMERICA, 2007, 34 (04) : 555 - +
  • [23] Testosterone Replacement Therapy and the Cardiovascular System
    Sahar Naderi
    Current Atherosclerosis Reports, 2016, 18
  • [24] Testosterone replacement therapy in the era of telemedicine
    Justin M. Dubin
    Richard J. Fantus
    Joshua A. Halpern
    International Journal of Impotence Research, 2022, 34 : 663 - 668
  • [25] Testosterone replacement therapy in the era of telemedicine
    Dubin, Justin M.
    Fantus, Richard J.
    Halpern, Joshua A.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2022, 34 (07) : 663 - 668
  • [26] Testosterone replacement therapy in men and women
    Coutinho, EM
    Maia, H
    Erdens, C
    HUMAN REPRODUCTION, 2005, : 531 - 538
  • [27] Testosterone replacement therapy and cardiovascular risk
    Gagliano-Juca, Thiago
    Basaria, Shehzad
    NATURE REVIEWS CARDIOLOGY, 2019, 16 (09) : 555 - 574
  • [28] THE INFLUENCE OF TESTOSTERONE REPLACEMENT THERAPY ON THE PROSTATE
    Mskhalaya, G. J.
    Tishova, Y. A.
    Kalinchenko, S. Yu
    Saad, F.
    JOURNAL OF MENS HEALTH, 2009, 6 (03) : 256 - 256
  • [29] Testosterone Replacement Therapy for Male Hypogonadism
    Heidelbaugh, Joel J.
    Belakovskiy, Aleksandr
    AMERICAN FAMILY PHYSICIAN, 2024, 109 (06) : 543 - 549
  • [30] TESTOSTERONE REPLACEMENT THERAPY AND CANCER RISK
    Eisenberg, Michael
    Betts, Paul
    Herder, Danielle
    Lamb, Dolores
    Lipshultz, Larry
    JOURNAL OF UROLOGY, 2013, 189 (04): : E617 - E618